ATF3 expression in the corpus luteum: Possible role in luteal regression

Dagan Mao, Xiaoying Hou, Heather Talbott, Robert Cushman, Andrea S Cupp, John S Davis

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The present study investigated the induction and possible role of activating transcription factor 3 (ATF3) in the corpus luteum. Postpubertal cattle were treated at midcycle with prostaglandin F2α(PGF) for 0-4 hours. Luteal tissue was processed for immunohistochemistry, in situ hybridization, and isolation of protein and RNA. Ovaries were also collected from midluteal phase and first-trimester pregnant cows. Luteal cells were prepared and sorted by centrifugal elutriation to obtain purified small (SLCs) and large luteal cells (LLCs). Real-time PCR and in situ hybridization showed that ATF3 mRNA increased within 1 hour of PGF treatment in vivo. Western blot and immunohistochemistry demonstrated that ATF3 protein was expressed in the nuclei of LLC within 1 hour and was maintained for at least 4 hours. PGF treatment in vitro increased ATF3 expression only in LLC, whereas TNF induced ATF3 in both SLCs and LLCs. PGF stimulated concentration- and time-dependent increases in ATF3 and phosphorylation of MAPKs in LLCs. Combinations of MAPK inhibitors suppressed ATF3 expression in LLCs. Adenoviral-mediated expression of ATF3 inhibited LH-stimulated cAMP response element reporter luciferase activity and progesterone production in LLCs and SLCs but did not alter cell viability or change the expression or activity of key regulators of progesterone synthesis. In conclusion, the action of PGF in LLCs is associated with the rapid activation of stress-activated protein kinases and the induction of ATF3, which may contribute to the reduction in steroid synthesis during luteal regression. ATF3 appears to affect gonadotropinstimulated progesterone secretion at a step or steps downstream of PKA signaling and before cholesterol conversion to progesterone.

Original languageEnglish (US)
Pages (from-to)2066-2079
Number of pages14
JournalMolecular Endocrinology
Volume27
Issue number12
DOIs
StatePublished - Dec 1 2013

Fingerprint

Activating Transcription Factor 3
Luteolysis
Luteal Cells
Corpus Luteum
Dinoprost
Progesterone
In Situ Hybridization
Immunohistochemistry
Response Elements
First Pregnancy Trimester
Heat-Shock Proteins
Luciferases
Protein Kinases
Real-Time Polymerase Chain Reaction
Ovary
Cell Survival
Proteins

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

ATF3 expression in the corpus luteum : Possible role in luteal regression. / Mao, Dagan; Hou, Xiaoying; Talbott, Heather; Cushman, Robert; Cupp, Andrea S; Davis, John S.

In: Molecular Endocrinology, Vol. 27, No. 12, 01.12.2013, p. 2066-2079.

Research output: Contribution to journalArticle

Mao, Dagan ; Hou, Xiaoying ; Talbott, Heather ; Cushman, Robert ; Cupp, Andrea S ; Davis, John S. / ATF3 expression in the corpus luteum : Possible role in luteal regression. In: Molecular Endocrinology. 2013 ; Vol. 27, No. 12. pp. 2066-2079.
@article{c81af318361048c8a698ec7e4a787302,
title = "ATF3 expression in the corpus luteum: Possible role in luteal regression",
abstract = "The present study investigated the induction and possible role of activating transcription factor 3 (ATF3) in the corpus luteum. Postpubertal cattle were treated at midcycle with prostaglandin F2α(PGF) for 0-4 hours. Luteal tissue was processed for immunohistochemistry, in situ hybridization, and isolation of protein and RNA. Ovaries were also collected from midluteal phase and first-trimester pregnant cows. Luteal cells were prepared and sorted by centrifugal elutriation to obtain purified small (SLCs) and large luteal cells (LLCs). Real-time PCR and in situ hybridization showed that ATF3 mRNA increased within 1 hour of PGF treatment in vivo. Western blot and immunohistochemistry demonstrated that ATF3 protein was expressed in the nuclei of LLC within 1 hour and was maintained for at least 4 hours. PGF treatment in vitro increased ATF3 expression only in LLC, whereas TNF induced ATF3 in both SLCs and LLCs. PGF stimulated concentration- and time-dependent increases in ATF3 and phosphorylation of MAPKs in LLCs. Combinations of MAPK inhibitors suppressed ATF3 expression in LLCs. Adenoviral-mediated expression of ATF3 inhibited LH-stimulated cAMP response element reporter luciferase activity and progesterone production in LLCs and SLCs but did not alter cell viability or change the expression or activity of key regulators of progesterone synthesis. In conclusion, the action of PGF in LLCs is associated with the rapid activation of stress-activated protein kinases and the induction of ATF3, which may contribute to the reduction in steroid synthesis during luteal regression. ATF3 appears to affect gonadotropinstimulated progesterone secretion at a step or steps downstream of PKA signaling and before cholesterol conversion to progesterone.",
author = "Dagan Mao and Xiaoying Hou and Heather Talbott and Robert Cushman and Cupp, {Andrea S} and Davis, {John S}",
year = "2013",
month = "12",
day = "1",
doi = "10.1210/me.2013-1274",
language = "English (US)",
volume = "27",
pages = "2066--2079",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "12",

}

TY - JOUR

T1 - ATF3 expression in the corpus luteum

T2 - Possible role in luteal regression

AU - Mao, Dagan

AU - Hou, Xiaoying

AU - Talbott, Heather

AU - Cushman, Robert

AU - Cupp, Andrea S

AU - Davis, John S

PY - 2013/12/1

Y1 - 2013/12/1

N2 - The present study investigated the induction and possible role of activating transcription factor 3 (ATF3) in the corpus luteum. Postpubertal cattle were treated at midcycle with prostaglandin F2α(PGF) for 0-4 hours. Luteal tissue was processed for immunohistochemistry, in situ hybridization, and isolation of protein and RNA. Ovaries were also collected from midluteal phase and first-trimester pregnant cows. Luteal cells were prepared and sorted by centrifugal elutriation to obtain purified small (SLCs) and large luteal cells (LLCs). Real-time PCR and in situ hybridization showed that ATF3 mRNA increased within 1 hour of PGF treatment in vivo. Western blot and immunohistochemistry demonstrated that ATF3 protein was expressed in the nuclei of LLC within 1 hour and was maintained for at least 4 hours. PGF treatment in vitro increased ATF3 expression only in LLC, whereas TNF induced ATF3 in both SLCs and LLCs. PGF stimulated concentration- and time-dependent increases in ATF3 and phosphorylation of MAPKs in LLCs. Combinations of MAPK inhibitors suppressed ATF3 expression in LLCs. Adenoviral-mediated expression of ATF3 inhibited LH-stimulated cAMP response element reporter luciferase activity and progesterone production in LLCs and SLCs but did not alter cell viability or change the expression or activity of key regulators of progesterone synthesis. In conclusion, the action of PGF in LLCs is associated with the rapid activation of stress-activated protein kinases and the induction of ATF3, which may contribute to the reduction in steroid synthesis during luteal regression. ATF3 appears to affect gonadotropinstimulated progesterone secretion at a step or steps downstream of PKA signaling and before cholesterol conversion to progesterone.

AB - The present study investigated the induction and possible role of activating transcription factor 3 (ATF3) in the corpus luteum. Postpubertal cattle were treated at midcycle with prostaglandin F2α(PGF) for 0-4 hours. Luteal tissue was processed for immunohistochemistry, in situ hybridization, and isolation of protein and RNA. Ovaries were also collected from midluteal phase and first-trimester pregnant cows. Luteal cells were prepared and sorted by centrifugal elutriation to obtain purified small (SLCs) and large luteal cells (LLCs). Real-time PCR and in situ hybridization showed that ATF3 mRNA increased within 1 hour of PGF treatment in vivo. Western blot and immunohistochemistry demonstrated that ATF3 protein was expressed in the nuclei of LLC within 1 hour and was maintained for at least 4 hours. PGF treatment in vitro increased ATF3 expression only in LLC, whereas TNF induced ATF3 in both SLCs and LLCs. PGF stimulated concentration- and time-dependent increases in ATF3 and phosphorylation of MAPKs in LLCs. Combinations of MAPK inhibitors suppressed ATF3 expression in LLCs. Adenoviral-mediated expression of ATF3 inhibited LH-stimulated cAMP response element reporter luciferase activity and progesterone production in LLCs and SLCs but did not alter cell viability or change the expression or activity of key regulators of progesterone synthesis. In conclusion, the action of PGF in LLCs is associated with the rapid activation of stress-activated protein kinases and the induction of ATF3, which may contribute to the reduction in steroid synthesis during luteal regression. ATF3 appears to affect gonadotropinstimulated progesterone secretion at a step or steps downstream of PKA signaling and before cholesterol conversion to progesterone.

UR - http://www.scopus.com/inward/record.url?scp=84888318436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888318436&partnerID=8YFLogxK

U2 - 10.1210/me.2013-1274

DO - 10.1210/me.2013-1274

M3 - Article

C2 - 24196350

AN - SCOPUS:84888318436

VL - 27

SP - 2066

EP - 2079

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 12

ER -